Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Dec;6(4):572-580.
doi: 10.1136/svn-2020-000803. Epub 2021 Apr 7.

Endovascular treatment in anterior circulation stroke beyond 6.5 hours after onset or time last seen well: results from the MR CLEAN Registry

Luuk Dekker  1 , Esmee Venema  2   3 , F Anne V Pirson  4 , Charles B L M Majoie  5 , Bart J Emmer  5 , Ivo G H Jansen  5 , Maxim J H L Mulder  6 , Robin Lemmens  7   8   9 , Robert-Jan B Goldhoorn  4 , Marieke J H Wermer  1 , Jelis Boiten  10 , Geert J Lycklama À Nijeholt  11 , Yvo B W E M Roos  12 , Adriaan C G M van Es  11   13 , Hester F Lingsma  3 , Diederik W J Dippel  6 , Wim H van Zwam  14 , Robert J van Oostenbrugge  4 , Ido R van den Wijngaard  1   10 ; MR CLEAN Registry investigators
Collaborators, Affiliations
Randomized Controlled Trial

Endovascular treatment in anterior circulation stroke beyond 6.5 hours after onset or time last seen well: results from the MR CLEAN Registry

Luuk Dekker et al. Stroke Vasc Neurol. 2021 Dec.

Abstract

Background: Randomised controlled trials with perfusion selection have shown benefit of endovascular treatment (EVT) for ischaemic stroke between 6 and 24 hours after symptom onset or time last seen well. However, outcomes after EVT in these late window patients without perfusion imaging are largely unknown. We assessed their characteristics and outcomes in routine clinical practice.

Methods: The Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands Registry, a prospective, multicentre study in the Netherlands, included patients with an anterior circulation occlusion who underwent EVT between 2014 and 2017. CT perfusion was no standard imaging modality. We used adjusted ordinal logistic regression analysis to compare patients treated within versus beyond 6.5 hours after propensity score matching on age, prestroke modified Rankin Scale (mRS), National Institutes of Health Stroke Scale, Alberta Stroke Programme Early CT Score (ASPECTS), collateral status, location of occlusion and treatment with intravenous thrombolysis. Outcomes included 3-month mRS score, functional independence (defined as mRS 0-2), and death.

Results: Of 3264 patients who underwent EVT, 106 (3.2%) were treated beyond 6.5 hours (median 8.5, IQR 6.9-10.6), of whom 93 (87.7%) had unknown time of stroke onset. CT perfusion was not performed in 87/106 (80.2%) late window patients. Late window patients were younger (mean 67 vs 70 years, p<0.04) and had slightly lower ASPECTS (median 8 vs 9, p<0.01), but better collateral status (collateral score 2-3: 68.3% vs 57.7%, p=0.03). No differences were observed in proportions of functional independence (43.3% vs 40.5%, p=0.57) or death (24.0% vs 28.9%, p=0.28). After matching, outcomes remained similar (adjusted common OR for 1 point improvement in mRS 1.04, 95% CI 0.56 to 1.93).

Conclusions: Without the use of CT perfusion selection criteria, EVT in the 6.5-24-hour time window was not associated with poorer outcome in selected patients with favourable clinical and CT/CT angiography characteristics. randomised controlled trials with lenient inclusion criteria are needed to identify more patients who can benefit from EVT in the late window.

Keywords: Stroke; Thrombectomy.

PubMed Disclaimer

Conflict of interest statement

Competing interests: Erasmus MC received funds from Stryker and Bracco Imaging by DWJD. MUMC received funds from Stryker and Codman for consultations by WHvZ. WHvZ and RJvO are principal investigators for the MR CLEAN-LATE trial. R-JBG and FAVP are coordinating researchers for MR CLEAN-LATE. CBLMM received funds from TWIN Foundation (related to this project, paid to institution) and from CVON/Dutch Heart Foundation, Stryker, European Commission, Health Evaluation Netherlands (unrelated; all paid to institution). YBWEMR, CBLMM and IGHJ are shareholders of Nico.lab, a company that focuses on the use of artificial intelligence for medical imaging analysis. RL reports institutional fees from Ischamaview for consultancy. The other authors had no conflicting interests.

Figures

Figure 1
Figure 1
Flowchart of patients. EVT, endovascular treatment; LSW, last seen well; MR CLEAN, Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands.
Figure 2
Figure 2
Distribution of mRS scores at 3 months. EVT, endovascular treatment; LSW, last seen well; mRS, modified Rankin Scale.
See this image and copyright information in PMC

References

    1. Goyal M, Menon BK, van Zwam WH, et al. . Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016;387:1723–31. 10.1016/S0140-6736(16)00163-X - DOI - PubMed
    1. Fiehler J, Cognard C, Gallitelli M, et al. . European recommendations on organisation of interventional care in acute stroke (EROICAS). Int J Stroke 2016;11:701–16. 10.1177/1747493016647735 - DOI - PubMed
    1. Powers WJ, Derdeyn CP, Biller J, et al. . 2015 American heart Association/American stroke association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American heart Association/American stroke association. Stroke 2015;46:3020–35. 10.1161/STR.0000000000000074 - DOI - PubMed
    1. Jadhav AP, Desai SM, Kenmuir CL, et al. . Eligibility for endovascular trial enrollment in the 6- to 24-hour time window: analysis of a single comprehensive stroke center. Stroke 2018;49:1015–7. 10.1161/STROKEAHA.117.020273 - DOI - PubMed
    1. Saver JL, Goyal M, van der Lugt A, et al. . Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 2016;316:1279–88. 10.1001/jama.2016.13647 - DOI - PubMed

Publication types

LinkOut - more resources